Help Save Lives: Co-Prescribe Naloxone to Patients at Risk of Overdose (PDF - 208 KB)
Lists factors that may help physicians determine whether to coprescribe naloxone to a patient or to a family member or close friend of the patient.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Lists factors that may help physicians determine whether to coprescribe naloxone to a patient or to a family member or close friend of the patient.
Describes risk factors for the development of opioid-related adverse events and how to mitigate these risks. Provides an overview of adverse events, including their symptoms and how to manage them.
The Council on Patient Safety in Women’s Health Care disseminates patient safety bundles to help facilitate the standardization process. This bundle reflects emerging clinical, scientific, and patient safety advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Although the components of a particular bundle may be adapted to local resources, standardization within an institution is strongly encouraged.
This toolkit provides tools to both providers and patients for the assessment and management of perinatal mood and anxiety disorders, as well as substance use disorders (SUD).